Lung Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Any age of male and female; 2) Lung cancer confirmed by histology or cytology; 3) No systematic treatment or surgical treatment with lung cancer as indication has been received in the past; 4) Be able to understand and follow instructions, and be able to perform CPET physically; 5) Volunteer to participate in clinical research and sign informed consent; 6) Patients with 10ml/kg / min<ppo-vo2max <= 20ml /kg/min.
Exclusion criteria
Exclusion criteria: 1) Paients that cannot cooperate with or have diseases that affect the results of CPET analysis: including (but not limited to) the history of syncope during exercise; unstable ischemic heart disease, NYHA class III / IV left ventricular failure, arrhythmia, uncontrolled hypertension, cerebrovascular disease, neuroskeletal muscle disease, serious metabolic disease and mental disease, uncontrolled thyroid function Hyperactivity, diabetes, severe depression, Alzheimer's disease; 2) Patients with respiratory tract infection within 4 weeks before screening or at screening stage. Patients can be screened again 4 weeks after the recovery of respiratory infection; 3) Patients with history of malignancies in any organ system in the past 5 years; 4) Patients with distant metastasis who are unable to perform surgery according to NCCN guideline 2019.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative complications;Cardiopulmonary exercise test;Pulmonary function;Borg score;Arterial blood gas; | — |
Countries
China
Contacts
Shanghai Pulmonary Hospital